Genetic susceptibility and oxidative stress in prostate cancer: integrated model with implications for prevention.

[1]  Cosette M Wheeler,et al.  Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. , 2005, The Lancet. Oncology.

[2]  T. Rebbeck,et al.  Association of Susceptibility Alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with Prostate Cancer Severity in European American and African American Men , 2005, Cancer Epidemiology Biomarkers & Prevention.

[3]  C. Maier,et al.  Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene , 2005, British Journal of Cancer.

[4]  R. Silverman,et al.  HPC1/RNASEL Mediates Apoptosis of Prostate Cancer Cells Treated with 2′,5′-Oligoadenylates, Topoisomerase I Inhibitors, and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand , 2004, Cancer Research.

[5]  H. Grönberg,et al.  Genetic Analysis of the RNASEL Gene in Hereditary, Familial, and Sporadic Prostate Cancer , 2004, Clinical Cancer Research.

[6]  G. Andriole,et al.  Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. , 2004, Urology.

[7]  Pär Stattin,et al.  H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. , 2004, Journal of the National Cancer Institute.

[8]  J. Carpten,et al.  Combined genome-wide scan for prostate cancer susceptibility genes. , 2004, Journal of the National Cancer Institute.

[9]  H. Grönberg,et al.  Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. , 2004, Cancer research.

[10]  John T. Wei,et al.  Elevated α-Methylacyl-CoA Racemase Enzymatic Activity in Prostate Cancer , 2004 .

[11]  E. Platz,et al.  Epidemiology of inflammation and prostate cancer. , 2004, The Journal of urology.

[12]  J. Carpten,et al.  Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates. , 2003, Cancer research.

[13]  C. Cobbs,et al.  High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. , 2003, The Journal of urology.

[14]  Michael M Lieber,et al.  The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.

[15]  T. Lehtimäki,et al.  New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men. , 2003, Journal of the National Cancer Institute.

[16]  A. Bowie,et al.  The Toll-IL-1 receptor adaptor family grows to five members. , 2003, Trends in immunology.

[17]  R. Silverman.  Implications for RNase L in prostate cancer biology. , 2003, Biochemistry.

[18]  David I. Smith,et al.  Mutations in CHEK2 associated with prostate cancer risk. , 2003, American journal of human genetics.

[19]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[20]  L. Villarreal,et al.  Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections , 2002, The Prostate.

[21]  J. Witte,et al.  RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases , 2002, Nature Genetics.

[22]  J. Carpten,et al.  Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk , 2002, Nature Genetics.

[23]  O. Bratt.  Hereditary prostate cancer: clinical aspects. , 2002, The Journal of urology.

[24]  L. Dennis,et al.  Epidemiologic association between prostatitis and prostate cancer. , 2002, Urology.

[25]  E. Bleecker,et al.  Associations between hOGG1 sequence variants and prostate cancer susceptibility. , 2002, Cancer research.

[26]  K. Klinger,et al.  Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 , 2002, Nature Genetics.

[27]  L. Dennis,et al.  Meta-Analysis of Measures of Sexual Activity and Prostate Cancer , 2002, Epidemiology.

[28]  E. Goode,et al.  Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  S. Gordon,et al.  Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. , 2001, The Journal of clinical investigation.

[30]  Siavash Ghaffari,et al.  A candidate prostate cancer susceptibility gene at chromosome 17p , 2001, Nature Genetics.

[31]  A. De Marzo,et al.  Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. , 2000, Urology.

[32]  J. Radicella,et al.  The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. , 2000, Archives of biochemistry and biophysics.

[33]  T. Kodama,et al.  Protection from Lethal Gram-Positive Infection by Macrophage Scavenger Receptor–Dependent Phagocytosis , 2000, The Journal of experimental medicine.

[34]  J. Epstein,et al.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. , 1999, The American journal of pathology.

[35]  E. Goode,et al.  Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. , 1999, American journal of human genetics.

[36]  F. Collins,et al.  Evidence for a prostate cancer susceptibility locus on the X chromosome. , 1998, Nature Genetics.

[37]  D. Shih,et al.  Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.

[38]  W. Vogel,et al.  Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. , 1998, American journal of human genetics.

[39]  D. Easton,et al.  Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators. , 1998, American journal of human genetics.

[40]  F. Collins,et al.  Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus , 1997 .

[41]  D. Easton,et al.  Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study. , 1997, British journal of urology.

[42]  M Feychting,et al.  Cancer in twins: genetic and nongenetic familial risk factors. , 1997, Journal of the National Cancer Institute.

[43]  D A Meyers,et al.  Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.

[44]  B. Lemaître,et al.  The Dorsoventral Regulatory Gene Cassette spätzle/Toll/cactus Controls the Potent Antifungal Response in Drosophila Adults , 1996, Cell.

[45]  T. Beaty,et al.  Hereditary prostate cancer: epidemiologic and clinical features. , 1993, The Journal of urology.

[46]  B. Ponder,et al.  Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. , 2003, American journal of human genetics.

[47]  K. V. van Dijk,et al.  Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis. , 2000, International journal of tissue reactions.